24 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:57 PM
Dishman Pharmaceuticals & Chemicals Ltd.

BSE

  • 289.95 -9.35 (-3.12%)
  • Vol: 393695
  • BSE Code: 532526
  • PREV. CLOSE
    299.30
  • OPEN PRICE
    300.00
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    287.85(110)

NSE

  • 288.70 0.00 (0%)
  • Vol: 1821394
  • NSE Code: DISHMAN
  • PREV. CLOSE
    288.70
  • OPEN PRICE
    300.90
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    288.70(36959)

Dishman Pharmaceuticals & Chemicals Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
08-Feb-201713-Feb-2017 Quarterly Results & Interim Dividend
19-Oct-201627-Oct-2016 Quarterly Results
26-Jul-201603-Aug-2016 Quarterly Results
22-Apr-201619-May-2016 Audited Results
08-Mar-201610-Mar-2016 Interim Dividend
03-Feb-201605-Feb-2016 Quarterly Results
07-Oct-201529-Oct-2015 Quarterly Results
26-Aug-201531-Aug-2015 Quarterly Results
17-Aug-201522-Aug-2015 Final Dividend & Audited Results
14-Jul-201517-Jul-2015 Audited Results & Final Dividend
25-May-201528-May-2015Dishman Pharmaceuticals and Chemicals Ltd has informed BSE that due to unavoidable circumstances, the Meeting of Board of Directors of Company which was scheduled to be held on May 25, 2015 is hereby postponed to May 28, 2015.
05-May-201525-May-2015 The Board of Directors of the Company will be held on May 25, 2015, inter alia, to consider and take on record, the Audited Financial Results of the Company for the year ended March 31, 2015, to recommend Final Dividend, if any, to approve Notice of Annual General Meeting (AGM), Directors' Report etc., to fix the dates of Book Closure & AGM etc. & Final Dividend & Audited Results
02-Feb-201513-Feb-2015 Quarterly Results
03-Nov-201412-Nov-2014 Quarterly Results
04-Aug-201413-Aug-2014 Quarterly Results & Dishman Pharmaceuticals and Chemicals Ltd has informed that a meeting of the Board of Directors of the Company will be held on August 13, 2014, inter alia, to consider and review the following business: 1. To consider and take on record the Unaudited Financial Results (Provisional) of the Company for the quarter ended June 30, 2014; 2. To consider and approve matter relating to issue of Shares to Qualified Institutional Person/ Investor (QIP); and 3. To consider and approve the matter relating to issue of shares to employee under Employee Stock Option Scheme (ESOP). Further, In view of the same, the trading window for the Designated Employees of the Company shall remain close from August 01, 2014 to August 14, 2014 (both days inclusive). During this period. Directors, Designated Employees and their dependents are required not to deal in the shares of the Company.